Teriparatide Completed Phase 4 Trials for Osteoporosis / Atypical Femoral Fractures Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01705587
Fracture (FX) Improvement With Teriparatide: FiX-IT Study